Literature DB >> 15163322

Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.

L A M Bashawri1, N A Fawaz, M S Ahmad, A A Qadi, W Y Almawi.   

Abstract

The prevalence of serological markers of HBV and HCV were determined for blood donors in eastern Saudi Arabia. Between 1998 and 2001, 13,443 donors (10,778 Saudi and 2665 non-Saudi), were screened for HBsAg, anti-HBc Ab, and anti-HCV Ab using commercial kits. There was a steady decrease in the HBsAg (2.58 and 1.67%), anti-HBc rates (15.32 and 9.15%), and anti-HCV (1.04 and 0.59%) rates between 1998 and 2001, respectively. However, there was a marked difference between Saudi and non-Saudi donors with regard to anti-HBc (P < 0.001) and anti-HCV (P < 0.01), but not HBsAg prevalence rates in the same time period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163322     DOI: 10.1111/j.1365-2257.2004.00601.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  22 in total

1.  Accuracy of rapid oral HCV diagnostic test among a Saudi sample.

Authors:  Suzan Ibrahim; Safia Ali Al Attas; Ghada Anwar Mansour; Soliman Ouda; Hind Fallatah
Journal:  Clin Oral Investig       Date:  2014-05-21       Impact factor: 3.573

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Prevalence of hepatitis B and C in donated blood from the jazan region of saudi arabia.

Authors:  Saleh Mohammed Abdullah
Journal:  Malays J Med Sci       Date:  2013-03

4.  Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.

Authors:  Hind I Fallatah; Hisham O Akbar; Yousif A Qari
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

5.  Viral hepatitis in Saudi Arabia. An unfinished story.

Authors:  Ayman A Abdo; Faisal M Sanai
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

Review 6.  Estimation of Cancer Burden Attributable to Infection in Asia.

Authors:  He Huang; Xiao-Feng Hu; Fang-Hui Zhao; Suzanne M Garland; Neerja Bhatla; You-Lin Qiao
Journal:  J Epidemiol       Date:  2015-09-19       Impact factor: 3.211

7.  Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia.

Authors:  Abdulaziz T Alshomrani
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

Review 8.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

9.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

10.  SASLT practice guidelines for the management of hepatitis B virus.

Authors:  Faisal Abaalkhail; Hussien Elsiesy; Ahmed AlOmair; Mohammed Y Alghamdi; Abduljaleel Alalwan; Nasser AlMasri; Waleed Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.